Filing Flows › Dentsply Sirona (XRAY) › Guidance & outlook
Dentsply Sirona (XRAY) guidance and outlook
Dentsply Sirona (XRAY) lowered its guidance on Nov 5, 2026: EPS $1.20–$1.30 for FY2026; EBITDA $39.0M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EPS | FY2026 | $1.20–$1.30 | lowered |
| EBITDA | FY2026 | $39.0M | new |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Dentsply Sirona's latest quarter
Dentsply Sirona, Q3 2026: revenue $836M (-8% year over year), operating margin 4.4%, net loss $3.0M, operating cash flow $32.0M. The chart follows the revenue to costs, profit and cash.
Questions
Did Dentsply Sirona raise or lower its guidance?
Dentsply Sirona (XRAY) lowered its guidance on Nov 5, 2026: EPS $1.20–$1.30 for FY2026; EBITDA $39.0M for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.